The program times are listed in Central European Time (CEST)

Displaying One Session

PARALLEL SESSION
Date
Wed, 02.06.2021
Session Type
PARALLEL SESSION
Session Time
20:10 - 21:40
Room
Hall A
PARALLEL SESSION

What do we need to develop/improve with the technology that we are using today

PARALLEL SESSION

Managing Diabetes Emergencies in a Digital World

PARALLEL SESSION

DEBATE: In the era of remote visits – do we still need A1c measures - PRO

Abstract

Abstract Body

Debate: In the Era of Remote Visits, Do We Still Need A1c Measures?

Fergus Cameron and Stuart A Weinzimer

Hemoglobin A1c has been the gold standard metric to assess glycemic control in people with type 1 diabetes since the Diabetes Control and Complications Trial, and subsequently has been adopted to other forms of diabetes, as well as for diagnosing diabetes. However, the rapidly increasing use of continuous glucose monitoring (CGM) has enabled clinicians to assess metrics of glycemia more directly; and with the growing popularity of telemedicine, driven most urgently in the past year by the COVID pandemic, the role of A1c as a clinically important measure has been questioned. In this debate, we will discuss the relative merits and limitations of A1c and CGM, and whether continuing use of A1c measures in clinical care is still warranted.

Hide
PARALLEL SESSION

DEBATE: In the era of remote visits – do we still need A1c measures - CON

Abstract

Abstract Body

Hemoglobin A1c has been the gold standard metric to assess glycemic control in people with type 1 diabetes since the Diabetes Control and Complications Trial and has subsequently been adopted to other forms of diabetes, as well as for the diagnosis of diabetes. However, the rapidly increasing use of continuous glucose monitoring (CGM) has enabled clinicians to assess metrics of glycemia more directly; and with the growing popularity of telemedicine, driven most urgently in the past year by the COVID pandemic, the role of A1c as a clinically important measure has been questioned. In this brief debate, we will discuss the relative merits and limitations of A1c and CGM, and whether continuing use of A1c measurement in clinical care is still warranted.

Hide
PARALLEL SESSION

Live Q&A